Note: Ingredients listed on restricted chemical lists
EC/CAS
204-658-1/123-86-4
Name of the chemical
acetic acid, butyl ester
Concentration
>=20.0-<30.0% >=10.0-<20.0%
EC/CAS
200-578-6/64-17-5
Name of the chemical
Ethanol
Concentration
>=10.0-<20.0%
EC/CAS
215-175-0/1309-64-4
Name of the chemical
Diantimontrioxid
Concentration
051-005- >=5.0-<10.0%
EC/CAS
25068-38-6
Name of the chemical
4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane
Concentration
>=0.1-<1.0%
EC/CAS
200-659-6/67-56-1
Name of the chemical
Methanol
Concentration
603-001- >=0.25-<0.3%
EC/CAS
205-250-6/136-52-7
Name of the chemical
Cobalt bis(2-ethylhexanoate)
Concentration
<0.1%
EC/CAS
200-001-8/50-00-0
Name of the chemical
Formaldehyde
Concentration
>=10.0-<20.0%
EC/CAS
215-263-9/1317-33-5
Name of the chemical
molybdenum disulphide
Concentration
>= 10.0 - < 20.0 %
General Information
Version
13.0
Revision date
2025-02-06
Product name
MOLYKOTE 3400A Anti-Friction Coating LF
1.2.1 Relevant identified uses
Lubricants and lubricant additives
Emergency telephone
+(44)-870-8200418
Icons in SDS
Company Information
company name
SPECIALTY ELECTRONIC MATERIALS UK
e-mail address of the competent person responsible for the Safety Data Sheet
SDSQuestion-EU@dupont.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H225, H317, H319, H336, H351
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Flammable liquids - Category 2 - H225 Eye irritation - Category 2 - H319 Skin sensitisation - Category 1 - H317 ® ™ Trademark of affiliates of DuPont de Nemours, Inc. Carcinogenicity - Category 2 - Inhalation - H351 Specific target organ toxicity - single exposure - Category 3 - H336 For the full text of the H-Statements mentioned in this Section, see Section 16.
Signal word
DANGER
Hazard statements
H225 Highly flammable liquid and vapour. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H336 May cause drowsiness or dizziness. H351 Suspected of causing cancer if inhaled.
Precautionary statements
P201 Obtain special instructions before use. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 Keep container tightly closed. P261 Avoid breathing mist or vapours. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P370 + P378 In case of fire: Use dry sand, dry chemical or alcohol-resistant foam to extinguish.
Additional information
EUH066 Repeated exposure may cause skin dryness or cracking.
Ingredient(s) with unknown acute toxicity
9.3981 % The following percentage of the mixture consists of ingredient(s) with unknown acute dermal toxicity: 23.3481 % The following percentage of the mixture consists of ingredient(s) with unknown acute inhalation toxicity: 9.3981 % The following percentage of the mixture consists of ingredient(s) with unknown hazards to the aquatic
Environmental hazards
9.3981 %
Contains
n-butyl acetate; antimony trioxide; 2-ethylhexanoic acid and its salts; formaldehyde
2.3 Other hazards
Static-accumulating flammable liquid. Endocrine disrupting properties (human health): This substance/mixture does not contain components considered to have endocrine disrupting properties for human health according to UK REACH Article 57(f) at levels of 0.1% or higher. Endocrine disrupting properties (environment): This substance/mixture does not contain components considered to have endocrine disrupting properties for environment according to UK REACH Article 57(f) at levels of 0.1% or higher.
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
